-+ 0.00%
-+ 0.00%
-+ 0.00%

The innovative drug concept rebounded. Harbin Pharmaceutical Co., Ltd. had 4 consecutive boards, Dizhe Pharmaceutical's 20cm2 continuous board, and Zhaoyan New Pharmaceutical hit a rise or fall, while Innox, Shiyao Innovation, Wisdom Pharmaceutical, and Borui Pharmaceutical followed suit.

Zhitongcaijing·07/15/2026 01:41:05
Listen to the news
The innovative drug concept rebounded. Harbin Pharmaceutical Co., Ltd. had 4 consecutive boards, Dizhe Pharmaceutical's 20cm2 continuous board, and Zhaoyan New Pharmaceutical hit a rise or fall, while Innox, Shiyao Innovation, Wisdom Pharmaceutical, and Borui Pharmaceutical followed suit.